Outcome predictors for patients receiving methadone maintenance treatment: findings from a retrospective multi-site study

References

• Abramsohn, Y., Peles, E., Potik, D., Schreiber, S., & Adelson, M. (2009). Sense of coherence as a stable predictor for methadone maintenance treatment (MMT) outcome. Journal of Psychoactive Drugs, 41, 249–253.
   PubMed Web of Science ®Google Scholar
• Alterman, A. I., Rutherford, M. J., Cacciola, J. S., McKay, J. R., & Boardman, C. R. (1998). Prediction of 7 months methadone maintenance treatment response by four measures of antisociality. Drug and Alcohol Dependence, 49, 217–223.
   PubMed Web of Science ®Google Scholar
• Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28, 321–329.
   PubMed Web of Science ®Google Scholar
• Anglin, M. D., Speckart, G. R., Booth, M. W., & Ryan, T. M. (1989). Consequences and costs of shutting off methadone. Addictive Behaviors, 14, 307–326.
   PubMed Web of Science ®Google Scholar
• Ashley, O. S., Marsden, M. E., & Brady, T. M. (2003). Effectiveness of substance abuse treatment programming for women: A review. American Journal of Drug and Alcohol Abuse, 29, 19–53.
   PubMed Web of Science ®Google Scholar
• Avants, S. K., Margolin, A., & McKee, S. (1999). A path analysis of cognitive, affective, and behavioral predictors of treatment response in a methadone maintenance program. Journal of Substance Abuse, 11, 215–230.
   Google Scholar
• Ball, J. C., Lange, W. R., Myers, C. P., & Friedman, S. R. (1988). Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior, 29, 214–226.
   PubMed Web of Science ®Google Scholar
• Banta-Green, C. J., Maynard, C., Koepsell, T. D., Wells, E. A., & Donovan, D. M. (2009). Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction, 104, 775–783.
   PubMed Web of Science ®Google Scholar
• Barry, D., Sullivan, B., & Petry, N. M. (2009). Comparable efficacy of contingency management for cocaine dependence among African American, Hispanic, and White methadone maintenance clients. Psychology of Addictive Behaviors, 23, 168–174.
   PubMed Web of Science ®Google Scholar
• Bell, J., Hall, W., & Byth, K. (1992). Changes in criminal activity after entering methadone maintenance. British Journal of Addiction, 87, 251–258.
   PubMedGoogle Scholar
• Bradley, C. J., French, M. T., & Rachal, V. (1994). Financing and cost of standard and enhanced methadone treatment. Journal of Substance Abuse Treatment, 11, 433–442.
   PubMed Web of Science ®Google Scholar
• Brooner, R. K., King, V. L., Kidorf, M., Schmidt, C. W., & Bigelow, G. E. (1997). Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry, 54, 71–80.
   PubMed Web of Science ®Google Scholar
• Bukten, A., Skurtveit, S., Gossop, M., Waal, H., Strangeland, P., Haynes, I., & Clausen, T. (2012). Engagement with opioid maintenance treatment and reductions in crime: A longitudinal national cohort study. Addiction, 107, 393–399.
   PubMed Web of Science ®Google Scholar
• Chaisson, R. E., Bacchetti, P., Osmond, D., Brodie, B., Sande, M. A., & Moss, A. R. (1989). Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA, 261, 561–565.
   PubMed Web of Science ®Google Scholar
• Del Rio, M., Mino, A., & Perneger, T. V. (1997). Predictors of patient retention in a newly established methadone maintenance treatment programme. Addiction, 92, 1353–1360.
   PubMed Web of Science ®Google Scholar
• DeMaria, P. A., Sterling, R., & Weinstein, S. P. (2000). The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. American Journal on Addictions, 9, 145–153.
   PubMed Web of Science ®Google Scholar
• Faggiano, F., Vigna-Taglianti, F., Versino, E., & Lemma, P. (2003). Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews, 3, CD002208.
   PubMedGoogle Scholar
• Fals-Stewart, W. (1997). Detection of neuropsychological impairment among substance-abusing patients: Accuracy of the Neurobehavioral Cognitive Status Examination. Experimental and Clinical Psychopharmacology, 5, 269–276.
   PubMed Web of Science ®Google Scholar
• Gerra, G., Borella, F., Zaimovic, A., Moi, G., Bussandri, M., Bubici, C., et al. (2004). Buprenorphine versus methadone for opioid dependence: Predictor variables for treatment outcome. Drug and Alcohol Dependence, 75, 37–45.
   PubMed Web of Science ®Google Scholar
• Ghodse, H., Clancy, C., Oyefeso, A., Rosinger, C., Finkbeiner, T., Schifano, F., et al. (2003). The impact of methadone substitution therapy (MST) on illicit drug use and drug abused-related quality of life: A European study. Heroin Addiction and Related Clinical Problems, 5, 5–16.
   Google Scholar
• Gibson, A., Degenhardt, L., Mattick, R. P., Ali, R., White, J., & O’Brien, S. (2008). Exposure to opioid maintenance treatment reduces long-term mortality. Addiction, 103, 462–468.
   PubMed Web of Science ®Google Scholar
• Goehl, L., Nunes, E., Quitkin, F., & Hilton, I. (1993). Social networks and methadone treatment outcome: The costs and benefits of social ties. American Journal of Drug and Alcohol Abuse, 19, 251–262.
   PubMed Web of Science ®Google Scholar
• Gryczynski, J., Schwartz, R. P., Salkever, D. S., Mitchell, S. G., & Jaffe, J. H. (2011). Patterns in admission delays to outpatient methadone treatment in the United States. Journal of Substance Abuse Treatment, 41, 431–439.
   PubMed Web of Science ®Google Scholar
• Hallinan, R., Ray, J., Byrne, A., Agho, K., & Attia, J. (2006). Therapeutic thresholds in methadone maintenance treatment: A receiver operating characteristic analysis. Drug and Alcohol Dependence, 81, 129–136.
   PubMed Web of Science ®Google Scholar
• Hartel, D. M., & Schoenbaum, E. E. (1998). Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City. Public Health Reports, 113, 107–115.
   PubMed Web of Science ®Google Scholar
• Haynes, I., Bukten, A., Gossop, M., Waal, H., Strangeland, P., & Clausen, T. (2012). Reductions in convictions for violent crime during opioid maintenance treatment: A longitudinal national cohort study. Drug and Alcohol Dependence, 124, 307–310.
   PubMed Web of Science ®Google Scholar
• Heinz, A. J., Wu, J., Witkiewitz, K., Epstein, D. H., & Preston, K. L. (2009). Marriage and relationship closeness as predictors of cocaine and heroin use. Addictive Behaviors, 34, 258–263.
   PubMed Web of Science ®Google Scholar
• Hodgins, D. C., El-Guebaly, N., & Addington, J. (1997). Treatment of substance abusers: Single or mixed gender programs? Addiction, 92, 805–812.
   PubMed Web of Science ®Google Scholar
• Hulse, G., English, D. R., Milner, E., & Holman, C. D. (1999). The quantification of mortality resulting from regular use of illicit opioids. Addiction, 94, 221–229.
   PubMed Web of Science ®Google Scholar
• Iguchi, M. Y., & Stitzer, M. L. (1991). Predictors of opiate drug abuse during a 90-day methadone detoxification. American Journal of Drug and Alcohol Abuse, 17, 279–294.
   PubMed Web of Science ®Google Scholar
• Joe, G. W., Chastain, R. L., Marsh, K. L., & Simpson, D. D. (1990). Relapse. In D. Simpson & S. Sells (Eds.), Opioid Addiction and Treatment: A 12-Year Follow-Up (pp. 121–136). Malabar, FL: Robert E. Krieger Publishing Co.
   Google Scholar
• Joe, G. W., Simpson, D. D., & Sells, S. B. (1994). Treatment process and relapse to opioid use during methadone maintenance. American Journal of Drug and Alcohol Abuse, 20, 173–197.
   PubMed Web of Science ®Google Scholar
• Judson, B. A., & Goldstein, A. (1982). Prediction of long-term outcome for heroin addicts admitted to a methadone maintenance program. Drug and Alcohol Dependence, 10, 383–391.
   PubMed Web of Science ®Google Scholar
• Leavitt, S. B., Shinderman, M., Maxwell, S., Eap, C. B., & Paris, P. (2000). When “enough” is not enough: New perspectives on optimal methadone maintenance dose. Mount Sinai Journal of Medicine, 67, 404–411.
   PubMed Web of Science ®Google Scholar
• Lehmann, F., Lauzon, P., & Amsel, R. (1993). Methadone maintenance: Predictors of outcome in a Canadian milieu. Journal of Substance Abuse Treatment, 10, 85–89.
   PubMed Web of Science ®Google Scholar
• Li, L., Ding, Y., Lai, W., Lin, C., & Luo, W. (2011). Motivational profiles of clients seeking methadone maintenance therapy in China. Drug and Alcohol Dependence, 118, 335–340.
   PubMed Web of Science ®Google Scholar
• Maddux, J. F., Prihoda, T. J., & Desmond, D. P. (1994). Treatment fees and retention on methadone maintenance. Journal of Drug Issues, 24, 429–443.
   Web of Science ®Google Scholar
• Magura, S., Nwakeze, P. C., & Demsky, S. (1998). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93, 51–60.
   PubMed Web of Science ®Google Scholar
• Maremmani, I., Pacini, M., Lubrano, S., & Lovrecic, M. (2003). When “enough” is still not enough: Effectiveness of high-dose methadone in the treatment of heroin addiction. Heroin Addiction and Related Clinical Problems, 5, 17–32.
   Google Scholar
• Mark, T. L., Woody, G. E., Juday, T., & Kleber, H. D. (2001). The economic costs of heroin addiction in the United States. Drug and Alcohol Dependence, 61, 195–206.
   PubMed Web of Science ®Google Scholar
• Marsch, L. A., (1998). The efficacy of methadone maintenance intervention in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction, 93, 515–532.
   PubMed Web of Science ®Google Scholar
• Maxwell, S., & Shinderman, M. (1999). Optimizing response to methadone maintenance treatment: Use of higher dose methadone. Journal of Psychoactive Drugs, 31, 95–102.
   PubMed Web of Science ®Google Scholar
• Muhleisen, P., Clark, N., Teo, A., & Brogan, D. (2005). Opioid substitution therapy: Considering the costs to consumers. Of Substance, 3, 14–17.
   Google Scholar
• Murphy, S., & Rosenbaum, M. (1988). Money for methadone II: Unintended consequences of limited-duration methadone maintenance. Journal of Psychoactive Drugs, 20, 397–402.
   PubMed Web of Science ®Google Scholar
• Newman, R. G. (1987). Methadone treatment: Defining and evaluating success. New England Journal of Medicine, 317, 447–450.
   PubMed Web of Science ®Google Scholar
• Nosyk, B., Geller, J., Guh, D. P., Oviedo-Joekes, E., Brissette, S., Marsh, D. C., et al. (2010). The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study. Drug and Alcohol Dependence, 111, 161–165.
   PubMed Web of Science ®Google Scholar
• Parrino, M. W. (2002). The renaissance of methadone treatment in America. Journal of Maintenance in the Addictions, 2, 5–17.
   Google Scholar
• Peles, E., Linzy, S., Kreek, M. J., & Adelson, M. (2008). One-year and cumulative retention as predictors of success in methadone maintencance treatment: A comparison of two clinics in the United Stated and Israel. Journal of Addictive Diseases, 27, 11–25.
   PubMed Web of Science ®Google Scholar
• Pilowsky, D. J., Wu, L., Burchett, B., Blazer, D. G., & Ling, W. (2011). Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: Results from the Clinical Trials Network. Substance Use & Misuse, 46, 1716–1725.
   PubMed Web of Science ®Google Scholar
• Saxon, A. J., Wells, E. A., Fleming, C., Jackson, T. R., & Calsyn, D. A. (1996). Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction, 91, 1197–1209.
   PubMed Web of Science ®Google Scholar
• Schottenfeld, R. S., Pakes, J. R., & Kosten, T. R. (1998). Prognostic factors in buprenorphine- versus methadone-maintained patients. Journal of Nervous and Mental Disease, 186, 35–43.
   PubMed Web of Science ®Google Scholar
• Silverman, K., Wong, C. J., Umbricht-Schneiter, A., Montoya, I. D., Schuster, C. R., & Preston, K. L. (1998). Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. Journal of Consulting and Clinical Psychology, 66, 811–824.
   PubMed Web of Science ®Google Scholar
• Simpson, D. D., Joe, G. W., Broome, K. M., Hiller, M. L., Knight, K., & Rowan-Szal, G. A. (1997). Program diversity and treatment retention rates in the Drug Abuse Treatment Outcomes Study (DATOS). Psychology of Addictive Behaviors, 11, 279–293.
   Web of Science ®Google Scholar
• Simpson, D. D., Joe, G. W., & Rowan-Szal, G. A. (1997). Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence, 47, 227–235.
   PubMed Web of Science ®Google Scholar
• Sorensen, J. L., & Copeland, A. L. (2000). Drug abuse treatment as an HIV prevention strategy: A review. Drug and Alcohol Dependence, 59, 17–31.
   PubMed Web of Science ®Google Scholar
• Soyka, M., Zingg, C., Koller, G., & Kuefner, H. (2008). Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome. Results from a randomized study. The International Journal of Neuropsychopharmacology, 11, 641–653.
   PubMed Web of Science ®Google Scholar
• Strain, E. C. (2002). Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. The Clinical Journal of Pain, 18, 14–27.
   PubMed Web of Science ®Google Scholar
• Strain, E. C., Bigelow, G. E., Liebson, I. A., & Stitzer, M. L. (1999). Moderate- vs. high-dose methadone in the treatment of opioid dependence: A randomized trial. JAMA, 281, 1000–1005.
   PubMed Web of Science ®Google Scholar
• Strain, E. C., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1993). Methadone dose and treatment outcome. Drug and Alcohol Dependence, 33, 105–117.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2011). Results from the 2010 national survey on drug use and health: Summary of national findings ( Office of Applied Studies, NSDUH Series H-41, HHS Publication No. SMA 11-4658). Rockville, MD: SAMHSA.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2014). Medicaid coverage and financing of medications to treat alcohol and opioid use disorders ( Office of Policy, Planning and Innovation, HHS Publication No. SMA 14-4854). Rockville, MD: SAMHSA.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2015). Targeted capacity expansion: Medication assisted treatment-prescription drug and opioid addiction (Grant Announcement). Rockville, MD: SAMHSA, Division of Grants Management. Retrived from: http://www.samhsa.gov/grants/grant-announcements
   Google Scholar
• Szapocznik, J., & Ladner, R. (1977). Factors related to successful retention in methadone maintenance: A Review. International Journal of the Addictions, 12, 1067–1085.
   PubMed Web of Science ®Google Scholar
• Torrens, M., Castillo, C., & Perez-Sola, V. (1996). Retention in a low-threshold methadone maintenance program. Drug and Alcohol Dependence, 41, 55–59.
   PubMed Web of Science ®Google Scholar
• Trafton, J. A., Minkel, J., & Humphreys, K. (2006). Determining effective methadone doses for individual opioid-dependent patients. PloS Medicine, 3, 380–387.
   Web of Science ®Google Scholar
• Wolff, K., & Hay, A. W. M. (1994). Plasma methadone monitoring with methadone maintenance treatment. Drug and Alcohol Dependence, 36, 69–75.
   PubMed Web of Science ®Google Scholar
• Wolff, K., & Hay, A. (1995). Methadone maintenance treatment: Treatment should be tailored for each patient. British Medical Journal, 310, 463–464.
   Google Scholar
• World Health Origanization. (2009). Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva, Switzerland: WHO Press.
   Google Scholar
• Zanis, D. A., & Woody, G. E. (1998). One-year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence, 52, 257–260.
   PubMed Web of Science ®Google Scholar